However, nine leading vaccine developers pledged to not submit their vaccines for approval until data from phase 3 trials shows that they meet predetermined safety and efficacy thresholds. value="https://yourdomain.co/your-webhook">, { e-mail us as much assistance as you require to get your data submitted to GEO. ,